High baseline fibrinogen concentration as a risk factor of no tissue reperfusion in ST-segment elevation acute

Jarosław Wasilewski1, Tadeusz Osadnik, Lech Poloński

  • 1III Katedra i Oddział Kliniczny Kardiologii SlAM, ul. Szpitalna 2, 41-800 Zabrze, Poland. jaroslaw-wasilewski@wp.pl

Kardiologia Polska
|October 21, 2006
PubMed

Insights

High baseline fibrinogen concentration is linked to poor myocardial reperfusion after angioplasty. This finding suggests fibrinogen impacts blood flow and heart tissue recovery following artery recanalization.

Area of Science:

  • Cardiology
  • Hematology
  • Vascular Biology

Background:

  • Myocardial infarction (MI) patients often experience impaired tissue reperfusion post-successful epicardial artery recanalization.
  • Microcirculation blood flow is influenced by vascular structure and blood rheology.

Purpose of the Study:

  • To determine the relationship between initial fibrinogen levels and myocardial reperfusion success after coronary angioplasty.
  • Investigate fibrinogen as a predictor for myocardial reperfusion in acute MI.

Main Methods:

  • Compared baseline fibrinogen in 105 acute ST-segment elevation MI patients.
  • Grouped patients based on successful tissue reperfusion (n=79) versus no reperfusion (n=26) via ST-segment normalization.
  • Analyzed correlation with cardiac biomarkers and chest pain duration.

Main Results:

  • No-reperfusion group had significantly higher baseline fibrinogen (523 mg/dl) vs. reperfusion group (395 mg/dl).
  • Fibrinogen correlated positively with peak creatine kinase-MB and chest pain duration.
  • Higher fibrinogen and longer chest pain duration independently increased no-reflow risk.

Conclusions:

  • Baseline fibrinogen is an independent risk factor for failed myocardial reperfusion post-angioplasty.
  • Elevated fibrinogen may impair blood rheology, contributing to the no-reflow phenomenon.
  • Fibrinogen concentration correlates with infarct size and symptom duration.
Abstract

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...